Position in MDGL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$577,757
+$140,660 QoQ
Shares Held
1,076
+28.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#238
of 411 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. MDGL ranks #18 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
66,580 | $16,296,786 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,020 | $15,905,293 | |
| 3 | TECH |
BIO-TECHNE Corp
|
137,966 | $9,747,297 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,330 | $3,323,466 | |
| 5 | ARGX |
Argenx SE
|
3,495 | $3,242,555 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
38,226 | $3,115,799 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
10,103 | $2,434,518 | |
| 8 | GMAB |
Genmab A/S
|
88,420 | $2,428,896 |
All Filings in MDGL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $577,757 | 1,076 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $437,097 | 835 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $256,811 | 441 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $177,959 | 388 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $117,121 | 387 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $170,251 | 514 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $151,507 | 491 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $119,479 | 563 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $221,886 | 792 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $196,006 | 734 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $322,312 | 1,393 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $328,151 | 2,247 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $557,634 | 2,414 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $465,380 | 1,921 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $145,125 | 500 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $23,266 | 358 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $11,166 | 156 | Shares | Defined | 2022-08-01 | |
| 2022-03-31 | $34,342 | 350 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $26,523 | 313 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,074 | 26 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $10,228 | 105 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $13,217 | 113 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $3,779 | 34 | Shares | Defined | 2021-02-04 | |
| 2020-09-30 | $949 | 8 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $906 | 8 | Shares | Defined | 2020-08-07 | |
| 2020-03-31 | $15,755 | 236 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||